MedTech News
Wearable blood pressure monitor attaches like a bandage for real-time continuous measurement
Seoul National University College of Engineering announced that a research team has developed a wearable electronic device that attaches to the skin like a bandage and enables real-time, continuous monitoring of blood pressure over extended periods.
SurgiBox Achieves CE Mark for SurgiField System Devices
SurgiBox, a medical technology company committed to improving access to safe, clean surgery at the point of need, announced today it has received the CE Mark under MDR for the medical devices that comprise its flagship product, the SurgiField System.
Natera introduces prenatal test for detecting inherited conditions
The introduction of the test is underpinned by data from the blinded, prospective EXPAND study, which began in 2023.
FDA Launches New PreCheck Program to Lower Regulatory Barriers to Pharma Manufacturing
Under PreCheck, the FDA will communicate more frequently with pharmaceutical companies, helping them as they establish or expand manufacturing sites in the U.S.
QinFlow Launches Advanced Fluid and Blood Warming Solution to Meet Critical Needs in ORs and ICUs
Founded in 2009, QinFlow is a market leader in fluid thermoregulation solutions.
Natural maple polyphenol found to inhibit tooth decay bacteria in new study
A new study in the journal Microbiology Spectrum highlights the potential of using a natural compound from maple to combat the bacteria responsible for tooth decay: Streptococcus mutans.
Full Market Launch of Cortium® Universal OCT Spinal Fixation System
PLANO, Texas, Aug. 7, 2025 /PRNewswire/ — ulrich medical USA, a leading medical device company focused on developing and commercializing spinal implant technologies, is proud to announce the full market launch of the Cortium® Universal OCT Spinal Fixation System, following a successful alpha release.
Instylla Gains U.S. FDA Premarket Approval for Embrace™ Hydrogel Embolic System
BEDFORD, Mass., Aug. 7, 2025 /PRNewswire/ — Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for the company’s flagship product Embrace™ Hydrogel Embolic System. Embrace HES has been approved for the embolization of hypervascular tumors in peripheral arteries ≤ 5mm.